346 related articles for article (PubMed ID: 17667799)
1. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
[TBL] [Abstract][Full Text] [Related]
2. A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrations.
Chen J; Boodhan S; Nanji M; Chang A; Sekharan S; Lavoratore S; Brandão LR; Skolnik JM; Dupuis LL
Pharmacotherapy; 2011 Aug; 31(8):776-84. PubMed ID: 21923604
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
[TBL] [Abstract][Full Text] [Related]
5. [Blood concentration monitoring during high-dose methotrexate treatment].
Jiao L; Zhou DB; Wang SJ; Zhang W; Duan MH; Li J; Han B; Xu Y; Zhao YQ; Shen T; Wang Q; Ye M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):564-6. PubMed ID: 19968071
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
[TBL] [Abstract][Full Text] [Related]
7. A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer.
Cole M; Price L; Parry A; Picton S; Waters F; Marshall S; Goran C; Parnham A; Wastell H; Reid MM; Pearson AD; Boddy AV; Veal GJ
Pediatr Blood Cancer; 2007 Jun; 48(7):687-95. PubMed ID: 16676305
[TBL] [Abstract][Full Text] [Related]
8. [Determination of methotrexate concentration in serum: comparison between capillary and venous blood].
Bömelburg T; Ritter J; Schellong G
Klin Padiatr; 1987; 199(3):230-2. PubMed ID: 3476803
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of tobramycin levels obtained from central venous access devices in patients with cystic fibrosis is technique dependent.
Mogayzel PJ; Pierce E; Mills J; McNeil A; Loehr K; Joplin R; McMahan S; Carson KA
Pediatr Nurs; 2008; 34(6):464-8; quiz 468-9. PubMed ID: 19263753
[TBL] [Abstract][Full Text] [Related]
10. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate Drug Monitoring From Central Access: Can Blood Sample Collection From Central Venous Access Replace Peripheral Venipuncture in Adults?
Aydilek E; Schanz J; Brökers N
Ther Drug Monit; 2023 Jun; 45(3):364-367. PubMed ID: 36863027
[TBL] [Abstract][Full Text] [Related]
12. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
[TBL] [Abstract][Full Text] [Related]
13. Examining the push-pull method of blood sampling from central venous access devices.
Adlard K
J Pediatr Oncol Nurs; 2008; 25(4):200-7. PubMed ID: 18539911
[TBL] [Abstract][Full Text] [Related]
14. Comparison of capillary earlobe and venous blood monitoring for occupational lead surveillance.
Taylor L; Jones RL; Ashley K; Deddens JA; Kwan L
J Lab Clin Med; 2004 Apr; 143(4):217-24. PubMed ID: 15085080
[TBL] [Abstract][Full Text] [Related]
15. [Permanent central venous catheter in pediatric oncology].
Nielsen PA; Jøhncke H; Due E
Ugeskr Laeger; 1989 Jun; 151(23):1470-2. PubMed ID: 2734952
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic drug monitoring of methotrexate after its administration in high-dose protocols].
Le Guellec C; Blasco H; Benz I; Hulin A;
Therapie; 2010; 65(3):163-9. PubMed ID: 20699066
[TBL] [Abstract][Full Text] [Related]
17. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
18. Extent of agreement in gentamicin concentration between serum that is drawn peripherally and from central venous catheters.
Boodhan S; Maloney AM; Dupuis LL
Pediatrics; 2006 Dec; 118(6):e1650-6. PubMed ID: 17088399
[TBL] [Abstract][Full Text] [Related]
19. [A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
Miyauchi Y; Mii Y; Morishita T; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Hino M; Nomura Y; Nakanishi E
Gan To Kagaku Ryoho; 1996 Apr; 23(5):595-9. PubMed ID: 8678518
[TBL] [Abstract][Full Text] [Related]
20. Comparing two methods to obtain blood specimens from pediatric central venous catheters.
Barton SJ; Chase T; Latham B; Rayens MK
J Pediatr Oncol Nurs; 2004; 21(6):320-6. PubMed ID: 15475468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
